BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 24854380)

  • 21. [Polymyalgia rheumatica: diagnostic and therapeutic issues of an apparently straightforward disease.].
    Manzo C; Camellino D
    Recenti Prog Med; 2017 May; 108(5):221-231. PubMed ID: 28643813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are polymyalgia rheumatica and giant cell arteritis the same disease?
    Cantini F; Niccoli L; Storri L; Nannini C; Olivieri I; Padula A; Boiardi L; Salvarani C
    Semin Arthritis Rheum; 2004 Apr; 33(5):294-301. PubMed ID: 15079760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Giant cell arteritis and polymyalgia rheumatica: diagnostic criteria].
    Marie I
    Rev Med Interne; 2013 Jul; 34(7):403-11. PubMed ID: 23498714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myalgias and Myopathies: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Mansalis K
    FP Essent; 2016 Jan; 440():16-22. PubMed ID: 26734832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain.
    Gonzalez-Gay MA; Garcia-Porrua C; Salvarani C; Olivieri I; Hunder GG
    J Rheumatol; 2000 Sep; 27(9):2179-84. PubMed ID: 10990231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current understanding and management of giant cell arteritis and polymyalgia rheumatica.
    Ghosh P; Borg FA; Dasgupta B
    Expert Rev Clin Immunol; 2010 Nov; 6(6):913-28. PubMed ID: 20979556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Giant cell arteritis and polymyalgia rheumatica presenting as subclavian artery obstruction].
    Sato M; Takeda A; Hagiwara S; Mochizuki M; Minato N; Saito K; Kano S
    Ryumachi; 1993 Aug; 33(4):330-4. PubMed ID: 8235915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Polymyalgia rheumatica and giant cell arteritis: what's new?].
    Nissen MJ; Gabay C
    Rev Med Suisse; 2010 Mar; 6(240):575-6, 578, 580. PubMed ID: 20408463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recommendations of diagnosis and treatment of giant cell arteritis and polymyalgia rheumatic in China].
    Wang P; Feng XB; Duan XW; Liu SY; Zhao Y
    Zhonghua Nei Ke Za Zhi; 2023 Mar; 62(3):256-266. PubMed ID: 36822851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
    Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
    Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practice.
    Lally L; Spiera R
    Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):803-812. PubMed ID: 31427056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in polymyalgia rheumatica.
    Owen CE; Buchanan RR; Hoi A
    Intern Med J; 2015 Nov; 45(11):1102-8. PubMed ID: 26036315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features of polymyalgia rheumatica and giant cell arteritis.
    Salvarani C; Pipitone N; Versari A; Hunder GG
    Nat Rev Rheumatol; 2012 Sep; 8(9):509-21. PubMed ID: 22825731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.
    Gonzalez-Gay MA; Garcia-Porrua C; Miranda-Filloy JA; Martin J
    Drugs Aging; 2006; 23(8):627-49. PubMed ID: 16964987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accuracy of self-reported diagnoses of polymyalgia rheumatica and giant cell arteritis in the French prospective E3N- EPIC cohort: A validation study.
    Barde F; Ascione S; Pacoureau L; Macdonald C; Salliot C; Boutron-Ruault MC; Seror R; Nguyen Y
    Semin Arthritis Rheum; 2024 Feb; 64():152298. PubMed ID: 38000317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases.
    Pujades-Rodriguez M; Duyx B; Thomas SL; Stogiannis D; Smeeth L; Hemingway H
    Heart; 2016 Mar; 102(5):383-9. PubMed ID: 26786818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concurrent baseline diagnosis of giant cell arteritis and polymyalgia rheumatica - A systematic review and meta-analysis.
    Nielsen AW; Frølund LL; Våben C; Bonde AR; Gormsen LC; de Thurah AL; Hauge EM; Keller KK
    Semin Arthritis Rheum; 2022 Oct; 56():152069. PubMed ID: 35858507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: influence on clinical subgroups and prognosis.
    Martínez-Taboda VM; Bartolome MJ; Lopez-Hoyos M; Blanco R; Mata C; Calvo J; Corrales A; Rodriguez-Valverde V
    Semin Arthritis Rheum; 2004 Aug; 34(1):454-64. PubMed ID: 15305244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Giant cell arteritis and rheumatica polymyalgia].
    Kotulska A; Kucharz EJ
    Pol Arch Med Wewn; 2000; 103(5-6):311-7. PubMed ID: 11291615
    [No Abstract]   [Full Text] [Related]  

  • 40. Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment.
    Martinez-Taboada VM; Alvarez L; RuizSoto M; Marin-Vidalled MJ; Lopez-Hoyos M
    Cytokine; 2008 Nov; 44(2):207-20. PubMed ID: 18986814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.